MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations - Wikidata - wikimedia - TriplyDB

MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations

MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations

http://www.wikidata.org/entity/Q42554932

about

Clinical significance of microRNAs in chronic and acute human leukemia MicroRNAs mediated regulation of MAPK signaling pathways in chronic myeloid leukemia Epigenomics of leukemia: from mechanisms to therapeutic applications miRNAs as Biomarkers in Chronic Myelogenous Leukemia Polymorphisms in microRNA target sites modulate risk of lymphoblastic and myeloid leukemias and affect microRNA binding.Altered expression pattern of miR-29a, miR-29b and the target genes in myeloid leukemia.Downregulated microRNA-148b in circulating PBMCs in chronic myeloid leukemia patients with undetectable minimal residual disease: a possible biomarker to discontinue imatinib safely.Lyn kinase-dependent regulation of miR181 and myeloid cell leukemia-1 expression: implications for drug resistance in myelogenous leukemia.Dysregulation of the mitogen granulin in human cancer through the miR-15/107 microRNA gene group MicroRNA gene dosage alterations and drug response in lung cancer Expression patterns of microRNAs associated with CML phases and their disease related targets.MicroRNA-486 regulates normal erythropoiesis and enhances growth and modulates drug response in CML progenitors Overexpression of miR-125a in myelodysplastic syndrome CD34+ cells modulates NF-κB activation and enhances erythroid differentiation arrest Characterization of miRNomes in acute and chronic myeloid leukemia cell lines.Specific Roles of MicroRNAs in Their Interactions with Environmental Factors.RalA, a GTPase targeted by miR-181a, promotes transformation and progression by activating the Ras-related signaling pathway in chronic myelogenous leukemia.MicroRNAs in leukemias: emerging diagnostic tools and therapeutic targets.BCR-ABL1 kinase-dependent alteration of mRNA metabolism: potential alternatives for therapeutic intervention.MicroRNA profiling in cancer.Epigenetic regulation of miRNA genes in acute leukemia.Role of epigenetics in chronic myeloid leukemia MicroRNAs in myeloid malignancies.New insights in cellular and molecular aspects of BM niche in chronic myelogenous leukemia.MicroRNAs as biomarkers for graft-versus-host disease following allogeneic stem cell transplantation.Preliminary data on microRNA expression profiles in a group of South African patients diagnosed with chronic myeloid leukaemia.The diagnosis, prognosis, and therapeutic application of MicroRNAs in haematological malignancies.PIK3C2A is a gene-specific target of microRNA-518a-5p in imatinib mesylate-resistant gastrointestinal stromal tumor.Targeting of the signal transducer Smo links microRNA-326 to the oncogenic Hedgehog pathway in CD34+ CML stem/progenitor cells.Biology of CML stem cells: the basis for clinical heterogeneity?The Beginning of the Road for Non-Coding RNAs in Normal Hematopoiesis and Hematologic Malignancies.Copy number variation analysis in cytochromes and glutathione S-transferases may predict efficacy of tyrosine kinase inhibitors in chronic myeloid leukemia.Down-regulation of miR-181c in imatinib-resistant chronic myeloid leukemia.miRNA expression correlated with morphological findings in chronic myeloid leukemia treated with imatinib mesylate.hsa_circRNA_103636: potential novel diagnostic and therapeutic biomarker in Major depressive disorder.Deregulation of linc-PINT in acute lymphoblastic leukemia is implicated in abnormal proliferation of leukemic cells.miR-505-5p and miR-193b-3p: potential biomarkers of imatinib response in patients with chronic myeloid leukemia.MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.Abnormal microRNA expression in the course of hematological malignancies

P2860

Q26749533-CDAAF3AB-9208-4C99-A39E-ADF4B7B9CFBB Q26766288-3F3C238F-F13B-4899-AFB6-CEA23C6E3A3A Q26823403-9C9A0B90-950A-4EE0-B52D-D500E0A19EE7 Q28087081-7380CFE6-58E0-465F-8421-2B5F184189BA Q33764157-416705D5-2318-4A8D-A5B9-EDB9BED010F3 Q33862129-9A8A5B5E-76BC-46B4-93B4-3069980A6581 Q34109784-292050DF-958E-4953-829A-2078E28B75E9 Q34309928-C909C6C9-8DD5-474D-9492-DCA3BBF17C52 Q34316489-1135CAB4-3B35-4839-BAD8-E20319915434 Q34897598-8B18CB54-CAC4-4152-9BDA-19BA76F154DF Q35009176-DC84EC7D-37C8-43C5-A539-96D3718A9176 Q35103557-986246F1-D366-4C1F-99B9-B06B734CBEE4 Q35137424-005B026F-8684-4E7B-A09F-6EC6F270BD5F Q35543478-66E0C84F-CF0A-411B-999E-87ECBA27A8BE Q36411230-45E8C77E-EDE6-4C38-9702-F748B3098E0E Q37190370-3DDC7327-E5EB-4337-957A-EF9D12534545 Q37724950-2EA656B8-07AD-43B3-9E61-63FC91A44D54 Q37836928-7CD92D37-757A-421A-A2A2-FE518FD66B13 Q37869934-980641F9-5550-4475-B321-D72B1CF78E1A Q37965026-B1DBE0D1-DBDD-414D-A373-6891F7560DEF Q38072315-02ECBF43-E6C3-4C01-821B-52FD7028F3EC Q38107272-CDA50E33-C567-4BF8-ACB9-F3B3459CEBAA Q38252432-26622479-4015-4F6F-BD45-82CCA9A57716 Q38434710-94FB4C6F-16BD-48DA-81A4-5217A3EA12A4 Q38637909-0767AC1A-E613-464E-A59C-63263C46D370 Q38747300-56CF8B10-D062-4461-A081-43528697BFA4 Q38788295-4979CAEB-1555-4147-98DA-CA612AA00F84 Q39206405-3B1CE926-D998-483A-BE81-5E1A393F6B7E Q39769583-27161665-60EC-4A12-9FE1-AB905B6392D0 Q40740405-60028ABA-FA12-4779-BB8B-5D52549F893E Q41144255-F3F70A98-07AD-4410-8F67-5DE650F4A0D4 Q41890535-8396851D-D3E0-443B-8CE0-78A44578B8FD Q45284614-62D81F0D-A6E2-4A94-99DC-E6992A7BA3CF Q48049122-5A1786CF-65F4-48B0-8557-DFC86CF42A01 Q52725331-B6D450CF-DAAE-4352-8364-C6D1F6630716 Q54010617-04C4AEC5-2B8D-4576-B872-227B5C2C994A Q54206519-46167D4C-D152-459C-ABA9-BCA0BE5CD10A Q57817341-27681E5F-D8D2-42B1-A973-184B47BEDC95

P2860

MicroRNA expression profiling in Imatinib-resistant Chronic Myeloid Leukemia patients without clinically significant ABL1-mutations

http://www.wikidata.org/entity/Q42554932

description

2009 nî lūn-bûn

@nan

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

2009年论文

@zh

2009年论文

@zh-cn

name

MicroRNA expression profiling ...... lly significant ABL1-mutations

@en

MicroRNA expression profiling ...... lly significant ABL1-mutations

@nl

type

label

MicroRNA expression profiling ...... lly significant ABL1-mutations

@en

MicroRNA expression profiling ...... lly significant ABL1-mutations

@nl

prefLabel

MicroRNA expression profiling ...... lly significant ABL1-mutations

@en

MicroRNA expression profiling ...... lly significant ABL1-mutations

@nl

P1433

Q42554932-34470F79-4416-4319-BB07-3838B26B09B4

P1476

Q42554932-BDFB3CE3-5E24-408C-B2E6-4C645C3F4A3D

P2093

Q42554932-312F49FB-1912-4D08-85B6-BC5FE0B303BF

Q42554932-52DA410D-5A35-4574-B293-DBCF715B2472

Q42554932-562562C9-FC83-410C-96F1-C833CB380C01

Q42554932-72CC24B3-80B0-4734-8640-30909CE28E86

Q42554932-9CC137B7-9DF3-419D-B033-B271A43F06C3

Q42554932-AE0F02F4-A8D5-46CF-B537-C212A184FC0C

Q42554932-E4952F51-3D05-4B15-B683-701D956C1C3B

Q42554932-F3246099-B2AD-4681-83AA-8B8E4720A181

Q42554932-F8D92D21-25AD-44F3-979E-6856C78738AF

Q42554932-FAE965FD-F1FC-4CB8-990C-F6E61A74F111

P2860

Q42554932-0AD622D4-A701-40D0-AA34-20389B86C0F3

Q42554932-17F4570A-514A-4D7C-8FED-F3AE092C4E46

Q42554932-1B9D3865-EEC3-44B4-85DD-FDA32493443D

Q42554932-30693358-6171-4D2F-9359-32E6C5AA5DBC

Q42554932-34177D1E-2D08-4DF1-8CFE-7282B4AE9921

Q42554932-6A5198DF-ED91-478B-BDBB-C5559A097F9F

Q42554932-76A03441-ADC7-45CE-A019-23395C2946F1

Q42554932-BD1F9151-AA28-47CE-8C00-69E98DF59786

Q42554932-E5403D03-22BE-483F-8A02-62CCDC8C09E6

Q42554932-FBB311DA-AE4F-4CA6-88E5-ED07521DC6CF

P2888

Q42554932-A1E23C80-2125-4086-A288-2681BB834EC0

P304

Q42554932-BB0232DA-2C4C-4E23-8B69-EEACE7CAE36C

P31

Q42554932-D3623CA7-AA0F-4683-9740-1C4A566E84A8

P356

Q42554932-9FA8FA00-3FC4-4386-9B97-CA2F4541E913

P478

Q42554932-09BFC817-C7A5-43FE-919D-7AEABDC0ABDD

P50

Q42554932-1CDC5460-E14D-4E24-8B3E-480D15BD7453

P577

Q42554932-3AD4B2CE-2EB3-4F1B-8EBE-13CE0B902CCA

P5875

Q42554932-BF993E03-2778-4C58-9F97-129B2B5ACBA0

P6179

Q42554932-19A4CDE9-066B-4364-9D01-6129FE461707

P698

Q42554932-1F31DEE2-5333-44AE-A8B7-365A29C10D8D

P921

Q42554932-9CA0D0F9-ECAD-4895-8D85-D9BE40FCAE73

Q42554932-E4C6874E-F052-42A8-B67E-7AEF7CE919B3

Q42554932-EDB2C90B-E2E7-4AE2-ACFC-C493E66F9D4E

P932

Q42554932-51036060-03D5-4854-97EE-341C45E0EA26

P356

P1433

Molecular Cancer

P1476

MicroRNA expression profiling ...... lly significant ABL1-mutations

@en

P2093

Amaia Vilas-Zornoza

http://www.w3.org/2001/XMLSchema#string

Antonio Jiménez-Velasco

http://www.w3.org/2001/XMLSchema#string

Edurne San José-Enériz

http://www.w3.org/2001/XMLSchema#string

José Román-Gómez

http://www.w3.org/2001/XMLSchema#string

Leire Garate

http://www.w3.org/2001/XMLSchema#string

Lucia Cordeu

http://www.w3.org/2001/XMLSchema#string

María José Calasanz

http://www.w3.org/2001/XMLSchema#string

Paula Rodríguez-Otero

http://www.w3.org/2001/XMLSchema#string

Vanesa Martin

http://www.w3.org/2001/XMLSchema#string

Xabier Agirre

http://www.w3.org/2001/XMLSchema#string

P2860

Role of MicroRNA miR-27a and miR-451 in the regulation of MDR1/P-glycoprotein expression in human cancer cells

MicroRNA expression profiles classify human cancers

miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells

Expression of the miR-17-92 polycistron in chronic myeloid leukemia (CML) CD34+ cells

Down-regulation of hsa-miR-10a in chronic myeloid leukemia CD34+ cells increases USF2-mediated cell growth

Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia

Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia.

Prognostic significance of, and gene and microRNA expression signatures associated with, CEBPA mutations in cytogenetically normal acute myeloid leukemia with high-risk molecular features: a Cancer and Leukemia Group B Study.

Hematopoietic-specific microRNA expression in human cells.

Gene expression signatures associated with the resistance to imatinib.

P2888

P304

69

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1476-4598-8-69

http://www.w3.org/2001/XMLSchema#string

P478

8

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26782746

http://www.w3.org/2001/XMLSchema#string

P6179

1024687121

http://www.w3.org/2001/XMLSchema#string

P698

19723306

http://www.w3.org/2001/XMLSchema#string

P921

microRNA expression

chronic myeloid leukemia

P932

2743636

http://www.w3.org/2001/XMLSchema#string